Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab
Retiro temprano de esteroides en una cohorte de trasplante renal tratada con tacrolimus, mofetil micofenolato y basiliximab
, Unidad de Investigación Médica en Enfermedades Renalesb, Jorge Andrade-Sierrac, Enrique Rojas-Camposd, Ernesto Cardona-Muñoze, Luis A. Evangelista-Carrillof, Abel Puentes-Camachof, Orlando Lugo-Lópezf, Benjamín Gómezf, Carlos Valdespinof, Ignacio Cerrillosf, Miguel Medina-Pérezf, Basilio Jalomof, Juan J. Nievesf, Mario Sandovalf, Francisco Ramos-Solanof, Francisco Monteón-Ramosf, Alfonso M. Cueto-Manzanod
b Unidad de Investigación en Enfermedades Renales, UMAE, Hospital de Especialidades, Guadalajara, Jalisco, México,
c Unidad de Investigación en Enfermedades Renales. Departamento de Nefrología y Unidad de Trasplante del Hospital de Especialidades, CMNO, IMSS. Departa, México.,
d Unidad de Investigación en Enfermedades Renales,
e Departamento de Fisiología. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara. Guadalajara, Jalisco. México,
f Departamento de Nefrología y Unidad de Trasplante del Hospital de Especialidades, CMNO, IMSS,
Read
10967
Timeswas read the article
2829
Total PDF
8138
Total HTML
Share statistics
array:21 [ "pii" => "X2013251414053752" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2013.Dec.12028" "estado" => "S300" "fechaPublicacion" => "2014-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2014;34:216-22" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6509 "formatos" => array:3 [ "EPUB" => 304 "HTML" => 5342 "PDF" => 863 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699514053755" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2013.Dec.12028" "estado" => "S300" "fechaPublicacion" => "2014-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2014;34:216-22" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8492 "formatos" => array:3 [ "EPUB" => 299 "HTML" => 7520 "PDF" => 673 ] ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Retiro temprano de esteroides en una cohorte de trasplante renal tratada con tacrolimus, mofetil micofenolato y basiliximab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "216" "paginaFinal" => "222" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_19904_48680_es_12028_t1.jpg" "Alto" => 462 "Ancho" => 700 "Tamanyo" => 294494 ] ] "descripcion" => array:1 [ "es" => "Características demográficas y trasplante." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => " Unidad de Investigación Médica en Enfermedades Renales, Jorge Andrade-Sierra, Enrique Rojas-Campos, Ernesto Cardona-Muñoz, Luis A. Evangelista-Carrillo, Abel Puentes-Camacho, Orlando Lugo-López, Benjamín Gómez, Carlos Valdespino, Ignacio Cerrillos, Miguel Medina-Pérez, Basilio Jalomo, Juan J. Nieves, Mario Sandoval, Francisco Ramos-Solano, Francisco Monteón-Ramos, Alfonso M. Cueto-Manzano" "autores" => array:18 [ 0 => null 1 => array:1 [ "apellidos" => "Unidad de Investigación Médica en Enfermedades Renales" ] 2 => array:2 [ "nombre" => "Jorge" "apellidos" => "Andrade-Sierra" ] 3 => array:2 [ "nombre" => "Enrique" "apellidos" => "Rojas-Campos" ] 4 => array:2 [ "nombre" => "Ernesto" "apellidos" => "Cardona-Muñoz" ] 5 => array:2 [ "nombre" => "Luis A." "apellidos" => "Evangelista-Carrillo" ] 6 => array:2 [ "nombre" => "Abel" "apellidos" => "Puentes-Camacho" ] 7 => array:2 [ "nombre" => "Orlando" "apellidos" => "Lugo-López" ] 8 => array:2 [ "nombre" => "Benjamín" "apellidos" => "Gómez" ] 9 => array:2 [ "nombre" => "Carlos" "apellidos" => "Valdespino" ] 10 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Cerrillos" ] 11 => array:2 [ "nombre" => "Miguel" "apellidos" => "Medina-Pérez" ] 12 => array:2 [ "nombre" => "Basilio" "apellidos" => "Jalomo" ] 13 => array:2 [ "nombre" => "Juan J." "apellidos" => "Nieves" ] 14 => array:2 [ "nombre" => "Mario" "apellidos" => "Sandoval" ] 15 => array:2 [ "nombre" => "Francisco" "apellidos" => "Ramos-Solano" ] 16 => array:2 [ "nombre" => "Francisco" "apellidos" => "Monteón-Ramos" ] 17 => array:2 [ "nombre" => "Alfonso M." "apellidos" => "Cueto-Manzano" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251414053752" "doi" => "10.3265/Nefrologia.pre2013.Dec.12028" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251414053752?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699514053755?idApp=UINPBA000064" "url" => "/02116995/0000003400000002/v0_201502091349/X0211699514053755/v0_201502091350/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251414053744" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2013.Dec.12226" "estado" => "S300" "fechaPublicacion" => "2014-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2014;34:223-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 10879 "formatos" => array:3 [ "EPUB" => 365 "HTML" => 9527 "PDF" => 987 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Tables for estimating the glomerular filtration rate using the new CKD-EPI equation from serum creatinine concentration" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "223" "paginaFinal" => "229" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tablas para la estimación del filtrado glomerular mediante la nueva ecuación CKD-EPI a partir de la concentración de creatinina sérica" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12226_16025_56350_en_t1.11.12226_02.jpg" "Alto" => 2628 "Ancho" => 2147 "Tamanyo" => 2083230 ] ] "descripcion" => array:1 [ "en" => "Calculation of the glomerular filtration rate according to serum creatinine concentration (mg/dl) and age using the CKD-EPI equation (white individuals)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Canal, Cristina Canal, R. Pellicer, Rodrigo Pellicer, C. Facundo, Carme Facundo, S. Gràcia-Garcia, Silvia Gràcia-Garcia, R. Montañés-Bermúdez, Rosario Montañés-Bermúdez, C. Ruiz-García, César Ruiz-García, M. Furlano, Mónica Furlano, I. DaSilva, Iara K. DaSilva, J. Ballarín, José A. Ballarín, J. Bover, Jordi Bover" "autores" => array:20 [ 0 => array:2 [ "Iniciales" => "C." "apellidos" => "Canal" ] 1 => array:2 [ "nombre" => "Cristina" "apellidos" => "Canal" ] 2 => array:2 [ "Iniciales" => "R." "apellidos" => "Pellicer" ] 3 => array:2 [ "nombre" => "Rodrigo" "apellidos" => "Pellicer" ] 4 => array:2 [ "Iniciales" => "C." "apellidos" => "Facundo" ] 5 => array:2 [ "nombre" => "Carme" "apellidos" => "Facundo" ] 6 => array:2 [ "Iniciales" => "S." "apellidos" => "Gràcia-Garcia" ] 7 => array:2 [ "nombre" => "Silvia" "apellidos" => "Gràcia-Garcia" ] 8 => array:2 [ "Iniciales" => "R." "apellidos" => "Montañés-Bermúdez" ] 9 => array:2 [ "nombre" => "Rosario" "apellidos" => "Montañés-Bermúdez" ] 10 => array:2 [ "Iniciales" => "C." "apellidos" => "Ruiz-García" ] 11 => array:2 [ "nombre" => "César" "apellidos" => "Ruiz-García" ] 12 => array:2 [ "Iniciales" => "M." "apellidos" => "Furlano" ] 13 => array:2 [ "nombre" => "Mónica" "apellidos" => "Furlano" ] 14 => array:2 [ "Iniciales" => "I." "apellidos" => "DaSilva" ] 15 => array:2 [ "nombre" => "Iara K." "apellidos" => "DaSilva" ] 16 => array:2 [ "Iniciales" => "J." "apellidos" => "Ballarín" ] 17 => array:2 [ "nombre" => "José A." "apellidos" => "Ballarín" ] 18 => array:2 [ "Iniciales" => "J." "apellidos" => "Bover" ] 19 => array:2 [ "nombre" => "Jordi" "apellidos" => "Bover" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699514053747" "doi" => "10.3265/Nefrologia.pre2013.Dec.12226" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699514053747?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251414053744?idApp=UINPBA000064" "url" => "/20132514/0000003400000002/v0_201502091616/X2013251414053744/v0_201502091616/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251414053760" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2014.Feb.12034" "estado" => "S300" "fechaPublicacion" => "2014-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2014;34:212-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5788 "formatos" => array:3 [ "EPUB" => 346 "HTML" => 4635 "PDF" => 807 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "212" "paginaFinal" => "215" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Genotipo de la haptoglobina y riesgo de nefropatía diabética en pacientes con diabetes mellitus tipo 1: estudio en población española" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12034_16025_56443_en_t1_9.12034_02.jpg" "Alto" => 531 "Ancho" => 2165 "Tamanyo" => 218567 ] ] "descripcion" => array:1 [ "en" => "Haptoglobin genotype and frequencies of the alleles in the population of the study" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio J. Amor, Silvia Canivell, Josep Oriola, Maria J. Ricart, Ana M. de Hollanda, Anna Bosch-Comas, Enric Esmatjes" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Antonio J." "apellidos" => "Amor" ] 1 => array:2 [ "nombre" => "Silvia" "apellidos" => "Canivell" ] 2 => array:2 [ "nombre" => "Josep" "apellidos" => "Oriola" ] 3 => array:2 [ "nombre" => "Maria J." "apellidos" => "Ricart" ] 4 => array:2 [ "nombre" => "Ana M." "apellidos" => "de Hollanda" ] 5 => array:2 [ "nombre" => "Anna" "apellidos" => "Bosch-Comas" ] 6 => array:2 [ "nombre" => "Enric" "apellidos" => "Esmatjes" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699514053763" "doi" => "10.3265/Nefrologia.pre2014.Feb.12034" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699514053763?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251414053760?idApp=UINPBA000064" "url" => "/20132514/0000003400000002/v0_201502091616/X2013251414053760/v0_201502091616/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "216" "paginaFinal" => "222" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => " Unidad de Investigación Médica en Enfermedades Renales, Jorge Andrade-Sierra, Enrique Rojas-Campos, Ernesto Cardona-Muñoz, Luis A. Evangelista-Carrillo, Abel Puentes-Camacho, Orlando Lugo-López, Benjamín Gómez, Carlos Valdespino, Ignacio Cerrillos, Miguel Medina-Pérez, Basilio Jalomo, Juan J. Nieves, Mario Sandoval, Francisco Ramos-Solano, Francisco Monteón-Ramos, Alfonso M. Cueto-Manzano" "autores" => array:18 [ 0 => null 1 => array:3 [ "apellidos" => "Unidad de Investigación Médica en Enfermedades Renales" "email" => array:1 [ 0 => "erojascampos@yahoo.com.mx" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Jorge" "apellidos" => "Andrade-Sierra" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 3 => array:3 [ "nombre" => "Enrique" "apellidos" => "Rojas-Campos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] 4 => array:3 [ "nombre" => "Ernesto" "apellidos" => "Cardona-Muñoz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "affe" ] ] ] 5 => array:3 [ "nombre" => "Luis A." "apellidos" => "Evangelista-Carrillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 6 => array:3 [ "nombre" => "Abel" "apellidos" => "Puentes-Camacho" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 7 => array:3 [ "nombre" => "Orlando" "apellidos" => "Lugo-López" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 8 => array:3 [ "nombre" => "Benjamín" "apellidos" => "Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 9 => array:3 [ "nombre" => "Carlos" "apellidos" => "Valdespino" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 10 => array:3 [ "nombre" => "Ignacio" "apellidos" => "Cerrillos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 11 => array:3 [ "nombre" => "Miguel" "apellidos" => "Medina-Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 12 => array:3 [ "nombre" => "Basilio" "apellidos" => "Jalomo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 13 => array:3 [ "nombre" => "Juan J." "apellidos" => "Nieves" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 14 => array:3 [ "nombre" => "Mario" "apellidos" => "Sandoval" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 15 => array:3 [ "nombre" => "Francisco" "apellidos" => "Ramos-Solano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 16 => array:3 [ "nombre" => "Francisco" "apellidos" => "Monteón-Ramos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] 17 => array:3 [ "nombre" => "Alfonso M." "apellidos" => "Cueto-Manzano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Unidad de Investigación en Enfermedades Renales, UMAE, Hospital de Especialidades, Guadalajara, Jalisco, México, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 1 => array:3 [ "entidad" => "Unidad de Investigación en Enfermedades Renales. Departamento de Nefrología y Unidad de Trasplante del Hospital de Especialidades, CMNO, IMSS. Departa, México., " "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 2 => array:3 [ "entidad" => "Unidad de Investigación en Enfermedades Renales, " "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] 3 => array:3 [ "entidad" => "Departamento de Fisiología. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara. Guadalajara, Jalisco. México, " "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "affe" ] 4 => array:3 [ "entidad" => "Departamento de Nefrología y Unidad de Trasplante del Hospital de Especialidades, CMNO, IMSS, " "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "afff" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Retiro temprano de esteroides en una cohorte de trasplante renal tratada con tacrolimus, mofetil micofenolato y basiliximab" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56435_en_t110.12028_i.jpg" "Alto" => 1418 "Ancho" => 2160 "Tamanyo" => 559396 ] ] "descripcion" => array:1 [ "en" => "Demographic and transplantation characteristics." ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">One of the great challenges in kidney transplant management is acute rejection (AR) but with the new immunosuppression regimen, the frequency of AR has decreased in recent decades, and we have observed a significant long-term improvement in graft and patient survival.<span class="elsevierStyleSup">1,2 </span>In Mexico, graft and patient survival is comparable to that reported in other countries.<span class="elsevierStyleSup">3,4 </span>However, there is still a considerable loss of renal grafts due to patient death with a functional graft (up to 40%),<span class="elsevierStyleSup">5 </span>in which cardiovascular disease is the main cause of mortality. Unfortunately, corticosteroids (as the basis for post-transplant immunosuppression) have been directly associated as one of the major cardiovascular risk factors.<span class="elsevierStyleSup">6,7</span></p><p class="elsevierStylePara">The prevalence of diabetes mellitus, obesity and metabolic syndrome in the general population is increasing,<span class="elsevierStyleSup">8,9 </span>and the risk of developing them after transplantation with the use of corticosteroids could be higher, thus leading to an increase in morbidity and mortality. In fact, the use of these drugs is associated with <span class="elsevierStyleItalic">de novo</span> diabetes after renal transplantation.<span class="elsevierStyleSup">10 </span>A strategy aimed at reducing these comorbidities is avoiding the use of, or the withdrawal of corticosteroids (whether it be late or early), after transplantation, whenever the risk of AR and graft survival are not compromised; however, the results in this regard have been controversial.<span class="elsevierStyleSup">11-13</span></p><p class="elsevierStylePara">Our population and probably some others are at greater risk of developing diabetes mellitus and other complications after renal transplantation, and as such, strategies for avoiding or reducing risk factors in this type of patient are necessary. Therefore, the objective of this study was to compare the effect of early steroid withdrawal (ESW) on the estimated glomerular filtration rate (eGFR), graft survival, frequency of AR and the metabolic profile in a renal transplantation cohort (ESW-C) treated with tacrolimus (TAC) and mycophenolate mofetil (MMF), in comparison with a control group (C-C) treated with the internationally recommended triple immunosuppression regimen (TAC, MMF and PDN).</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">MATERIAL AND METHOD</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">A retrospective cohort study was carried out on 32 renal graft recipients at the CMNO, IMSS Specialist Hospital in whom corticosteroid treatment was withdrawn. These patients received transplantations between December 2005 and July 2009, and were followed up until July 2010. During the study period, a total of 989 renal transplantations were performed (48 deceased donor), mostly from related living donors. Most patients selected received transplants from living donors (58/60) and all had a low immunological risk (panel reactive antibody against HLA classes I and II <30%). The ESW is an intervention that is very infrequently performed in our hospital and the decision to withdraw corticosteroids was taken by the nephrologist in accordance with the patient’s characteristics and their experience. We included all of the patients for whom corticosteroids were withdrawn during this period (ESW-C); the C-C consisted of recipients who had the same transplantation time, immunosuppression regime and immunological risk. Patients with a history of using corticosteroids before transplantation, diabetes mellitus, delayed renal graft function (those requiring renal replacement therapy immediately after transplantation) and multiple organ transplantation were excluded.</p><p class="elsevierStylePara">All patients received our hospital’s standard induction immunosuppression regimen based on: 0.18mg/kg/day TAC (divided into two doses), 2g/day MMF (divided into two doses), 500mg intravenous methylprednisolone (MPD) (peri-operatively) and 20mg of basiliximab peri-operatively and four days after transplantation. Oral maintenance therapy was performed with 2g/day MMF and 0.15mg/kg/day TAC, with an adjustment in accordance with serum levels (9-15ng/ml in the first 30 days and 8-10ng/ml during follow-up).</p><p class="elsevierStylePara">The ESW was carried out as follows: one day before and during transplantation (peri-operatively), patients received 500mg/day MPD, followed by 250, 125, 60 and 30g/day in days 1, 2, 3 and 4, respectively. The total withdrawal of steroids was carried out five days after transplantation. The C-C received maintenance immunosuppression with prednisone, in accordance with international recommendations, combined with TAC and MMF.</p><p class="elsevierStylePara">The following clinical and biochemical variables were obtained from medical registries in the post-transplantation phase: age, sex, family history of diabetes mellitus, personal history of pregnancy (females), cause of kidney disease, type of and time on renal replacement therapy, weight, height, blood pressure, glucose, total cholesterol, total cholesterol linked to high-density lipoproteins (HDL) and cholesterol linked to low-density lipoproteins (LDL), triglycerides, HLA, risk of infection by the cytomegalovirus (CMV), time of ischaemia and use of antihypertensive drugs and/or statins.</p><p class="elsevierStylePara">All assessments were carried out after 3, 6 and 12 months, and subsequently, each year in the post-transplantation period, and information was collected, such as: time of transplantation, immunosuppressant maintenance dose, episodes of AR, type and dose of anti-rejection therapy (MPD or polyclonal antibodies), medication (antihypertensive drugs, statins, hypoglycaemic agents). Risk of CMV infection was classified in accordance with the serological result of the ELISA for CMV (IgG): high risk: positive donor/negative recipient; intermediate risk: positive donor/positive recipient; low risk: negative donor/negative recipient.<span class="elsevierStyleSup">14,15</span></p><p class="elsevierStylePara">eGFR was calculated using the formula MDRD-4<span class="elsevierStyleSup">16</span> (MDRD [ml/min/1.73m<span class="elsevierStyleSup">2</span>] = 186x [creatinine/88.4]<span class="elsevierStyleSup">-1,154</span> x age<span class="elsevierStyleSup">-0,203</span> x 0.742 if the patient was female). The results of protocol biopsies were recorded (which have been carried out for ten years in our hospital as a matter of course, 3, 6 and 12 months after transplantation); furthermore, we recorded indicated biopsy results (whether due to renal dysfunction or proteinuria) and all the biopsies were assessed by the same nephrologist using the Banff histopathological classification.<span class="elsevierStyleSup">17 </span>The study was assessed and approved by the Local Research and Ethics Committee.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold"> </span></span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Statistical analysis</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">Data are displayed as mean ± standard deviation or numbers and percentages. The Student’s t-test and χ<span class="elsevierStyleSup">2</span> tests were used for comparisons between groups. Graft survival was assessed by Kaplan-Meier and the comparisons were carried out using the Log-rank test. The Cox proportional hazards model was used to assess the influence of steroid withdrawal at the start of AR. The statistical analyses were carried out using the SPSSä version 17 software (SPSS, Inc., Chicago, IL).</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">RESULTS</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The transplantation demographic characteristics are displayed in Table 1. We did not find differences between the groups in terms of the age or gender of the donor and recipient, the type of donor, a history of diabetes, the risk of CMV, the date and type of dialysis or compatibility of the HLA. Two grafts were transplanted from deceased donors in the ESW-C and the rest of the grafts came from living donors. Warm ischaemia was shorter in the ESW-C, while the C-C had a longer follow-up period.</p><p class="elsevierStylePara">The clinical and biochemical comparisons at the start of the study and at follow-up are displayed in Table 2. At the start of the study, ESW-C patients had significantly lower blood pressure, lower total cholesterol and triglycerides and higher HDL concentrations than the controls, although, the percentage of patients who used antihypertensive drugs and statins was not significantly different. At the end of follow-up, patients in the C-C had higher blood pressure, glucose, triglycerides, total cholesterol and LDL and a higher percentage of statin use than those of the ESW-C. At the end of follow-up, only one patient developed PTDM and this patient was in the C-C.</p><p class="elsevierStylePara">Curiously, the percentage of patients who used antihypertensive drugs decreased significantly in the ESW-C from 66% to 13% at the end of the study, which was significantly lower than the percentage of use in the C-C.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold"> </span></span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Graft function and acute rejection</span></p><p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold"> </span></span></p><p class="elsevierStylePara">Graft survival (defined as a loss of ≥30% of GFR) is displayed in Figure 1A. ESW-C patients had significantly better renal function than the controls (<span class="elsevierStyleItalic">p</span>=<span class="elsevierStyleItalic">.</span>04). When we compared renal function (measured by serum creatinine or eGFR), there were no differences between the cohorts in the baseline assessment; however, at the end of follow-up, ESW-C patients had better graft function (Figure 1B and Table 3). With regard to the histopathological results (# biopsies indicated for each cohort), there were 9 cases (15%) of AR in the first 3 months and 9 cases (30%) at the end of follow-up (Table 4). The accumulated incidence of AR was significantly lower (<span class="elsevierStyleItalic">P</span>=<span class="elsevierStyleItalic">.</span>04) in the ESW-C (19%) than in the C-C (43%). The Cox proportional hazards model was used to assess potential predictors of AR, such as independent variables included in the immunosuppression regimen (ESW 1, control 0), HLA, age, sex and serum cholesterol. However, none of these variables were significant independent predictors of AR (c<span class="elsevierStyleSup">2 </span>model 2.63, <span class="elsevierStyleItalic">P=</span>.76).</p><p class="elsevierStylePara">Table 4 displays the histopathological results of the renal biopsies. Nine episodes of AR were found in the protocol biopsies carried out within the first 3 months after transplantation; of the patients in the ESW-C, 3 had borderline AR and 2 had Banff IA AR, while the controls had 2 Banff IA AR, 1 Banff IIA AR and 1 acute humoral rejection. In the biopsies carried out after between 9 and 12 months (whether by protocol or indicated), of the patients in the ESW-C, 1 had Banff IA AR, while of those in the C-C, 5 had borderline AR and 3 had Banff IA AR. The latter findings were significantly different between cohorts (<span class="elsevierStyleItalic">P</span>=.006). Three C-C patients had chronic vascular disease of the graft in the biopsies conducted after 1 year of follow-up. Moreover, toxicity due to TAC was found in 23 patients (36 events of toxicity): 14 patients (61%) of the ESW-C and 9 patients (39%) of the C-C (<span class="elsevierStyleItalic">P</span>=.21). Of these, 10 patients (4 of the ESW-C/6 of the C-C) were changed to sirolimus and the GFR was not different between these two groups <span class="elsevierStyleBold">(72.31±22.80, 74.37±19.75, <span class="elsevierStyleItalic">p</span>=.82)</span>, and none had AR.</p><p class="elsevierStylePara">Despite the higher frequency of toxicity by TAC (confirmed by biopsy) in the ESW-C, levels of the drug in blood were not significantly different between the cohorts and they were within the therapeutic range in all cases (Table 3).</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">Corticosteroids are currently used in most renal transplantation centres around the world. However, there is a growing tendency to avoid their use due to their side effects and the negative impact on graft and patient survival, even at low doses.<span class="elsevierStyleSup">18-20 </span>Results of various studies in which steroids have been withdrawn have been controversial, probably due to the heterogeneity of the different immunosuppression protocol used, based on cyclosporine, TAC, azathioprine, MMF, rapamycin or everolimus,<span class="elsevierStyleSup">12,21 </span>with or without antibodies (monoclonal or polyclonal).<span class="elsevierStyleSup">13,22-24 </span>In the Latin American population, there are no data available for this intervention, especially with homogeneous immunosuppression regimens based on TAC and MMF. Nowadays, there is a documented higher risk in the development of obesity and diabetes in various populations,<span class="elsevierStyleSup">8,9 </span>which could be exacerbated after renal transplantation (and corticosteroids could be a major risk factor). In our setting, a higher risk of <span class="elsevierStyleItalic">de novo</span> diabetes after transplantation was associated with corticosteroid use;<span class="elsevierStyleSup">10 </span>medical interventions such as ESW may be beneficial in transplant recipients. Obviously, this intervention must not increase the risk of AR or decrease renal function. Initially, only patients with a low immunological risk and who ideally use potent immunosuppressive drugs would be candidates for steroid withdrawal.</p><p class="elsevierStylePara">We included patients who met these requirements and our results were similar to those of other studies carried out in similar conditions.<span class="elsevierStyleSup">25 </span>One of the main concerns with the withdrawal of corticosteroids was the greater risk of AR. The results of some studies that have reported a high rate<span class="elsevierStyleSup">13 </span>of AR are questionable, since a significant number of them did not perform renal biopsies (gold standard) or even reported the methodology for diagnosing AR, which could explain the results of a higher AR rate. In this study, AR was documented with protocol or indicated biopsies, and as such, both subclinical and clinical rejections were identified. Our results with ESW did not predict the development of AR or the incidence of AR during the first year and this was consistent with that reported by other hospitals.<span class="elsevierStyleSup">26 </span>Most late episodes of AR were documented in biopsies carried out due to an increase in serum creatinine and were more common in C-C (29%) than in ESW-C (3%). A possible explanation for this result is that the ESW-C had higher toxicity due to TAC documented histopathologically than the C-C, in spite of patients in the ESW-C receiving lower doses of TAC (data not displayed). From a pharmacological point of view, corticosteroids are cytochrome P450 inducer stimulants (isoenzyme CYA4) responsible for the biotransformation of TAC, and in ESW, this favours greater bioavailability of TAC, which may explain why patients with ESW had greater toxicity due to TAC and a lower rate of AR.<span class="elsevierStyleSup">27,28 </span>In the C-C, the eGFR was lower in comparison with that of the ESW-C, which could be explained by the higher rate of AR observed in this group during follow-up. The withdrawal of steroids could potentially improve the haemodynamic and metabolic profile. González-Molina et al.<span class="elsevierStyleSup">29</span> retrospectively assessed 923 kidney recipients (deceased donor) with steroid withdrawal and found lower blood pressure, total cholesterol and triglycerides. In this study, both groups had an appropriate control of blood pressure and serum lipids; however, ESW-C achieved this control with the use of a lower dose and frequency of drugs and these results were consistent with other studies.<span class="elsevierStyleSup">13 </span>These results have encouraged us to continue this intervention in our population through clinical trials to test these findings.</p><p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">CONCLUSION</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">In patients with a low immunological risk, with an immunosuppression regimen based on TAC and MMF, ESW does not change graft survival, renal function or the rate of AR in this cohort. Toxicity due to TAC (confirmed by biopsy) tends to be more common in ESW-C than in the controls and the reason for this merits further research. ESW-C patients had a lower requirement for antihypertensive drugs and hypolipidaemic agents in comparison with the C-C, which suggests a better metabolic profile. Our findings require further clinical trials in homogenous populations in order to avoid controversy with this type of intervention.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The authors declare that they have no conflicts of interest related to the contents of this article.</p><p class="elsevierStylePara"><a href="grande/12028_16025_56435_en_t110.12028_i.jpg" class="elsevierStyleCrossRefs"><img src="12028_16025_56435_en_t110.12028_i.jpg" alt="Demographic and transplantation characteristics."></img></a></p><p class="elsevierStylePara">Table 1. Demographic and transplantation characteristics.</p><p class="elsevierStylePara"><a href="grande/12028_16025_56436_en_t210.12028_i2.jpg" class="elsevierStyleCrossRefs"><img src="12028_16025_56436_en_t210.12028_i2.jpg" alt="Clinical and biochemical comparisons between the cohorts at the start and end of follow-up."></img></a></p><p class="elsevierStylePara">Table 2. Clinical and biochemical comparisons between the cohorts at the start and end of follow-up.</p><p class="elsevierStylePara"><a href="grande/12028_16025_56437_en_t3_10.12028_i4.jpg" class="elsevierStyleCrossRefs"><img src="12028_16025_56437_en_t3_10.12028_i4.jpg" alt="Comparison of renal function between cohorts at the start and end of follow-up."></img></a></p><p class="elsevierStylePara">Table 3. Comparison of renal function between cohorts at the start and end of follow-up.</p><p class="elsevierStylePara"><a href="grande/12028_16025_56438_en_t4_10.12028_i4.jpg" class="elsevierStyleCrossRefs"><img src="12028_16025_56438_en_t4_10.12028_i4.jpg" alt="Histopathological findings in renal biopsies carried out after 3 or &"></img></a></p><p class="elsevierStylePara">Table 4. Histopathological findings in renal biopsies carried out after 3 or &</p><p class="elsevierStylePara"><a href="grande/12028_16025_56439_en_f1_10.12028_i3.jpg" class="elsevierStyleCrossRefs"><img src="12028_16025_56439_en_f1_10.12028_i3.jpg" alt="Comparison of survival in accordance with the study cohort. B. Comparison of renal function in each cohort."></img></a></p><p class="elsevierStylePara">Figure 1. Comparison of survival in accordance with the study cohort. B. Comparison of renal function in each cohort.</p>" "pdfFichero" => "P1-E567-S4547-A12028-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec438759" "palabras" => array:1 [ 0 => "Función del injerto" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec438761" "palabras" => array:1 [ 0 => "Retiro temprano de esteroides" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec438763" "palabras" => array:1 [ 0 => "Rechazo agudo" ] ] ] "en" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec438760" "palabras" => array:1 [ 0 => "Graft function" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec438762" "palabras" => array:1 [ 0 => "Early steroid withdrawal" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec438764" "palabras" => array:1 [ 0 => "Acute rejection" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes: </span>No hay suficiente evidencia sobre la frecuencia de rechazo agudo y la función del injerto en los pacientes con retiro temprano de esteroides (RTE). El objetivo del presente estudio es comparar el efecto del RTE sobre la tasa de filtrado glomerular (TFG), la supervivencia/rechazo del injerto en receptores de una cohorte de tratados con tacrolimus/mofetil micofenolato, comparada con un grupo control. <span class="elsevierStyleBold">Material y métodos:</span> Cohorte retrospectiva en 60 receptores de bajo riesgo inmunológico entre diciembre de 2005 y julio de 2010. Cohorte del estudio (C-RTE; N = 32), el RTE se hizo el 5º día mientras recibían tacrolimus/mofetil micofenolato. La cohorte control (C-C, N = 28) recibió prednisona/tacrolimus/mofetil micofenolato. Las variables clínicas, bioquímicas e histológicas fueron evaluadas al inicio del estudio, y a los 3, 6 y 12 meses de seguimiento. Se utilizó Kaplan-Meier y el modelo de riesgos proporcionales de Cox para evaluar la supervivencia. Las comparaciones entre cohortes fueron hechas por la <span class="elsevierStyleItalic">t</span> de Student y <span class="elsevierStyleItalic">c<span class="elsevierStyleSup">2</span></span>. <span class="elsevierStyleBold">Resultados</span><span class="elsevierStyleBold">:</span> Durante el seguimiento, la C-C muestra presión sanguínea significativamente mayor tanto sistólica (125 ± 10 frente a 114 ± 8) como diastólica (81 ± 8 frente a 72 ± 7), glucosa sérica (96 ± 13 frente a 86 ± 10), triglicéridos (177 ± 61 frente a 129 ± 34), colesterol total (183 ± 43 frente a 148 ± 34) y colesterol LDL (100 ± 22 frente a 87 ± 25). La C-C presentó una mayor proporción de uso de antihipertensivos (57 frente a 13 %) y de estatinas (27 frente a 9 %). La TFGe fue mejor en la C-RTE que en la C-C (85,4 ± 20,6 frente a 70,6 ± 17,0, <span class="elsevierStyleBold">p</span> <span class="elsevierStyleBold">=</span> <span class="elsevierStyleBold">0,004</span>). La frecuencia de rechazo agudo fue menor en la C-RTE. <span class="elsevierStyleBold">Conclusiones</span><span class="elsevierStyleBold">:</span> La supervivencia del injerto, la TFG, la tasa de rechazo agudo y el perfil metabólico fueron mejores en la C-RTE que en la C-C.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Background:</span> Acute rejection and graft function have not been completely clarified in early-steroid-withdrawal (ESW) patients. The objective of this study was to compare the effect of early steroid withdrawal on GFR, graft survival/rejection in recipients in a cohort treated with tacrolimus/mycophenolate mofetil compared to a control cohort. <span class="elsevierStyleBold">Material and method:</span> Retrospective cohort, in 60 low immunological risk recipients between December 2005 and July 2010. Study cohort (ESW-C N=32), steroid withdrawal was carried out after 5 days, while they were receiving tacrolimus/mycophenolate mofetil. The control cohort (C-C, N=28) received prednisone/tacrolimus/mycophenolate mofetil. Clinical, biochemical and histological variables were assessed at baseline and after 3, 6, and 12 months of follow-up. Kaplan-Meier and the Cox proportional hazards model were used to assess survival. Comparisons between cohorts were carried out by the Student’s t and <span class="elsevierStyleItalic">c<span class="elsevierStyleSup">2</span></span> tests. <span class="elsevierStyleBold">Results:</span> At follow-up, C-C displayed significantly higher systolic (125±10 <span class="elsevierStyleItalic">vs.</span> 114±8) and diastolic (81±8 <span class="elsevierStyleItalic">vs.</span> 72±7) blood pressure, serum glucose (96±13 vs. 86±10), triglycerides (177±61 <span class="elsevierStyleItalic">vs.</span> 129±34), total (183±43 <span class="elsevierStyleItalic">vs.</span><span class="elsevierStyleItalic"> </span>148±34) and LDL-cholesterol (100±22 <span class="elsevierStyleItalic">vs.</span> 87±25). C-C had a higher proportion of antihypertensive (57 <span class="elsevierStyleItalic">vs.</span> 13%), and statins (27 <span class="elsevierStyleItalic">vs.</span> 9%) use. eGFR was better in ESW-C than in C-C (85.4±20.6 <span class="elsevierStyleItalic">vs.</span> 70.6±17.0, <span class="elsevierStyleBold"><span class="elsevierStyleItalic">p</span></span><span class="elsevierStyleBold">=.004</span>). AR frequency was lower in ESW-C. <span class="elsevierStyleBold">Conclusions:</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold"> </span></span>Graft survival, GFR, AR rate and metabolic profile were better in the ESW-C than in C-C.</p>" ] ] "multimedia" => array:5 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56435_en_t110.12028_i.jpg" "Alto" => 1418 "Ancho" => 2160 "Tamanyo" => 559396 ] ] "descripcion" => array:1 [ "en" => "Demographic and transplantation characteristics." ] ] 1 => array:8 [ "identificador" => "fig2" "etiqueta" => "Tab. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56436_en_t210.12028_i2.jpg" "Alto" => 782 "Ancho" => 2160 "Tamanyo" => 431618 ] ] "descripcion" => array:1 [ "en" => "Clinical and biochemical comparisons between the cohorts at the start and end of follow-up." ] ] 2 => array:8 [ "identificador" => "fig3" "etiqueta" => "Tab. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56437_en_t3_10.12028_i4.jpg" "Alto" => 436 "Ancho" => 2165 "Tamanyo" => 208367 ] ] "descripcion" => array:1 [ "en" => "Comparison of renal function between cohorts at the start and end of follow-up." ] ] 3 => array:8 [ "identificador" => "fig4" "etiqueta" => "Tab. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56438_en_t4_10.12028_i4.jpg" "Alto" => 654 "Ancho" => 2165 "Tamanyo" => 202746 ] ] "descripcion" => array:1 [ "en" => "Histopathological findings in renal biopsies carried out after 3 or &" ] ] 4 => array:8 [ "identificador" => "fig5" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12028_16025_56439_en_f1_10.12028_i3.jpg" "Alto" => 1432 "Ancho" => 1018 "Tamanyo" => 194056 ] ] "descripcion" => array:1 [ "en" => "Comparison of survival in accordance with the study cohort. B. Comparison of renal function in each cohort." ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Sola E, Gonzalez-Molina M, Cabello M, Burgos D, Ramos J, Gutierrez C, et al. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study. Transplantation 2010;89:714-20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20035250" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Moreso F, Alonso A, Gentil MA, González-Molina M, Capdevila L, Marcén R, et al. Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case-control study. Transpl Int 2010;23:907-13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20230537" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cueto-Manzano AM, Rojas E, Rosales G, Gómez B, Martínez HR, Cortés-Sanabria L, et al. Risk factors for long-term graft loss in kidney transplantation: experience of a Mexican single-center. Rev Invest Clin 2002;54:492-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12685215" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Monteón FJ, Gómez B, Valdespino C, Chávez S, Sandoval M, Flores A, et al. The kidney transplant experience at Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara México. Clin Transpl 2003:165-74." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000;57:307-13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10620213" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 2008;8:593-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18294155" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Vanrenterghem YF, Claes K, Montagnino G, Fieuws S, Maes B, Villa M, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008;85:209-16. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18212625" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy L, Rojas R, Villalpando-Hernández S, Hernández-Avila M, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Aguilar-Salinas CR, Gomez-Perez FJ, Franco A, Rios-Torres JM, Valles V, Olaiz G, et al. Prevalence of the metabolic syndrome diagnosed using the WHO criteria in a Nation Wide survey in Mexico. Diabetes 2002;51:A218." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Andrade-Sierra J, Contreras AM, Monteon FJ, Celis A, Gutierrez R, Montañez JL, et al. Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients. Arch Med Res 2006;37:961-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17045111" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000;11:1910-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11004223" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Opelz G, Döhler B, Laux G; Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005;5:720-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15760395" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010;89:1-14. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20061913" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Freeman RB, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, et al. Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation 2004;78:1765-73. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15614149" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010;89:779-95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20224515" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753-60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18294345" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Matas AJ. Minimization of steroids in kidney transplantation. Transpl Int 2009;22:38-48. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18662366" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Rike AH, Mogilishetty G, Alloway RR, Succop P, Roy-Chaudhury P, Cardi M, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008;22:229-35. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18339144" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Humar A, Kandaswamy R, Payne W, Gruessner R, Sutherlad D, Kasiske B, Spong R, Gillingham K, Matas AJ. 6 years of prednisone-free maintenance immunosupression. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006:6:S482." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, et al. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine. Transplant Proc 2005;37:788-90. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15848532" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "ter Meulen CG, van Riemsdijk I, Hené RJ, Christiaans MH, Borm GF, van Gelder T, et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant 2004;4:803-10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15084178" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, et al. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant 2005;5:157-66. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15636625" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gallon LG, Winoto J, Leventhal JR, Parker MA, Kaufman DB. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol 2006;1:1029-38. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17699323" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Vanrenterghem Y, van Hooff JP, Squifflet JP, Salmela K, Rigotti P, Jindal RM, et al. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant 2005;5:87-95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15636615" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "U.S. Renal Data System U B, MD. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2009." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hesselink DA, Ngyuen H, Wabbijn M, Gregoor PJ, Steyerberg EW, van Riemsdijk IC, et al. Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids. Br J Clin Pharmacol 2003;56:327-30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12919182" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "van Duijnhoven EM, Boots JM, Christiaans MH, Stolk LM, Undre NA, van Hooff JP. Increase in tacrolimus trough levels after steroid withdrawal. Transpl Int 2003;16:721-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12827231" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gonzalez-Molina M, Gentil MA, Burgos D, Cabello M, Cobelo C, Bustamante J, et al. Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study. NDT Plus 2010;3(Suppl_2):ii32-ii36. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20508858" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003400000002/v0_201502091616/X2013251414053752/v0_201502091616/en/main.assets" "Apartado" => array:4 [ "identificador" => "35441" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003400000002/v0_201502091616/X2013251414053752/v0_201502091616/en/P1-E567-S4547-A12028-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251414053752?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 12 | 8 | 20 |
| 2024 October | 51 | 58 | 109 |
| 2024 September | 61 | 38 | 99 |
| 2024 August | 70 | 82 | 152 |
| 2024 July | 54 | 44 | 98 |
| 2024 June | 72 | 57 | 129 |
| 2024 May | 55 | 48 | 103 |
| 2024 April | 57 | 45 | 102 |
| 2024 March | 50 | 31 | 81 |
| 2024 February | 37 | 37 | 74 |
| 2024 January | 45 | 42 | 87 |
| 2023 December | 33 | 24 | 57 |
| 2023 November | 44 | 29 | 73 |
| 2023 October | 44 | 46 | 90 |
| 2023 September | 38 | 38 | 76 |
| 2023 August | 31 | 49 | 80 |
| 2023 July | 44 | 37 | 81 |
| 2023 June | 38 | 35 | 73 |
| 2023 May | 52 | 44 | 96 |
| 2023 April | 41 | 18 | 59 |
| 2023 March | 44 | 35 | 79 |
| 2023 February | 50 | 19 | 69 |
| 2023 January | 55 | 41 | 96 |
| 2022 December | 68 | 30 | 98 |
| 2022 November | 51 | 30 | 81 |
| 2022 October | 76 | 44 | 120 |
| 2022 September | 65 | 39 | 104 |
| 2022 August | 60 | 48 | 108 |
| 2022 July | 39 | 47 | 86 |
| 2022 June | 51 | 32 | 83 |
| 2022 May | 34 | 37 | 71 |
| 2022 April | 41 | 44 | 85 |
| 2022 March | 54 | 40 | 94 |
| 2022 February | 39 | 40 | 79 |
| 2022 January | 49 | 22 | 71 |
| 2021 December | 59 | 41 | 100 |
| 2021 November | 40 | 31 | 71 |
| 2021 October | 53 | 36 | 89 |
| 2021 September | 38 | 43 | 81 |
| 2021 August | 44 | 41 | 85 |
| 2021 July | 52 | 43 | 95 |
| 2021 June | 46 | 20 | 66 |
| 2021 May | 48 | 31 | 79 |
| 2021 April | 86 | 75 | 161 |
| 2021 March | 62 | 38 | 100 |
| 2021 February | 59 | 13 | 72 |
| 2021 January | 48 | 23 | 71 |
| 2020 December | 49 | 15 | 64 |
| 2020 November | 42 | 17 | 59 |
| 2020 October | 40 | 21 | 61 |
| 2020 September | 48 | 18 | 66 |
| 2020 August | 37 | 14 | 51 |
| 2020 July | 50 | 12 | 62 |
| 2020 June | 45 | 15 | 60 |
| 2020 May | 43 | 16 | 59 |
| 2020 April | 48 | 20 | 68 |
| 2020 March | 38 | 16 | 54 |
| 2020 February | 42 | 22 | 64 |
| 2020 January | 55 | 32 | 87 |
| 2019 December | 62 | 25 | 87 |
| 2019 November | 53 | 24 | 77 |
| 2019 October | 36 | 14 | 50 |
| 2019 September | 42 | 38 | 80 |
| 2019 August | 34 | 13 | 47 |
| 2019 July | 37 | 21 | 58 |
| 2019 June | 40 | 25 | 65 |
| 2019 May | 59 | 20 | 79 |
| 2019 April | 114 | 34 | 148 |
| 2019 March | 64 | 33 | 97 |
| 2019 February | 40 | 21 | 61 |
| 2019 January | 60 | 31 | 91 |
| 2018 December | 109 | 57 | 166 |
| 2018 November | 117 | 23 | 140 |
| 2018 October | 113 | 25 | 138 |
| 2018 September | 76 | 23 | 99 |
| 2018 August | 70 | 19 | 89 |
| 2018 July | 61 | 22 | 83 |
| 2018 June | 74 | 20 | 94 |
| 2018 May | 81 | 18 | 99 |
| 2018 April | 68 | 8 | 76 |
| 2018 March | 80 | 11 | 91 |
| 2018 February | 53 | 10 | 63 |
| 2018 January | 70 | 7 | 77 |
| 2017 December | 76 | 21 | 97 |
| 2017 November | 73 | 17 | 90 |
| 2017 October | 62 | 18 | 80 |
| 2017 September | 43 | 12 | 55 |
| 2017 August | 44 | 15 | 59 |
| 2017 July | 35 | 18 | 53 |
| 2017 June | 66 | 20 | 86 |
| 2017 May | 45 | 18 | 63 |
| 2017 April | 46 | 16 | 62 |
| 2017 March | 29 | 30 | 59 |
| 2017 February | 58 | 10 | 68 |
| 2017 January | 36 | 11 | 47 |
| 2016 December | 107 | 10 | 117 |
| 2016 November | 123 | 16 | 139 |
| 2016 October | 188 | 14 | 202 |
| 2016 September | 218 | 5 | 223 |
| 2016 August | 256 | 10 | 266 |
| 2016 July | 281 | 15 | 296 |
| 2016 June | 180 | 0 | 180 |
| 2016 May | 191 | 0 | 191 |
| 2016 April | 148 | 0 | 148 |
| 2016 March | 133 | 0 | 133 |
| 2016 February | 145 | 0 | 145 |
| 2016 January | 178 | 0 | 178 |
| 2015 December | 174 | 0 | 174 |
| 2015 November | 147 | 0 | 147 |
| 2015 October | 126 | 0 | 126 |
| 2015 September | 117 | 0 | 117 |
| 2015 August | 96 | 0 | 96 |
| 2015 July | 97 | 0 | 97 |
| 2015 June | 57 | 0 | 57 |
| 2015 May | 60 | 0 | 60 |
| 2015 April | 13 | 0 | 13 |
Show all
